Latest news
Loading news…
Scipher Medicine
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Waltham, Massachusetts, United States Founded 2014 51-100 employees For Profit
Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient.
Scipher Medicine on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Scipher Medicine was acquired by Chemomab in 2026 for $15M.
Total Funding
$217M
Funding Rounds
5
Last Funding
Acquisitions
2
Monthly Visits
Contacts
87
Patents
18
5 trademarks
About Scipher Medicine
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
- Valuation range
- $500M to $1B
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 21
- Patents granted
- 18
- Trademarks
- 5
- IT spend
- $1.46M
Company Info
- Founded
- 2014
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 70
- HQ
- Waltham, Massachusetts, United States
- Region
- Greater Boston Area, East Coast, New England
- Exit date
- Jul 8, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 5.8
- Trend (30d)
- 9.2
- Trend (90d)
- 8.6
- Last leadership hire
- Nov 16, 2021
Scipher Medicine Funding Rounds
5 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 5Show
Page 1 / 1
Scipher Medicine Acquisitions
2 results
| Acquiree Name | Acquirer Name | Acquiree Industries | Acquiree Hq Country | ||
|---|---|---|---|---|---|
| Chemomab | $150M | 2026-07-08 | Scipher Medicine | BiotechnologyHealth CarePharmaceutical | Israel |
| CrossBridge Health | — | 2023-01-10 | Scipher Medicine | AnalyticsCustomer ServiceHealth CareMedicalPharmaceuticalSaaS | United States |
1–2 of 2Show
Page 1 / 1
Scipher Medicine Key People
Co-Founder
87
professional contacts at Scipher Medicine
Contact execs at Scipher Medicine →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Scipher Medicine
Loading news…
FAQs about Scipher Medicine
People who checked this page also checked these
Sectors Scipher Medicine invests & acquires in
Browse the full Acquirezy directory.